Hart Daniel Ryan has been a registered insider since 2003.
As Chief Financial Officer at Peregrine Pharmaceuticals Inc., Hart Daniel Ryan last made a transaction on 4/10/2023.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 1 |
100% |
343% |
-- |
-- |
1 Year |
1 |
0% |
-- |
-- |
-- |
| 1 |
100% |
156% |
-- |
-- |
9 Month |
1 |
0% |
-- |
-- |
-- |
| 1 |
100% |
89% |
-- |
-- |
6 Month |
1 |
0% |
-- |
-- |
-- |
| 1 |
100% |
46% |
-- |
-- |
3 Month |
1 |
0% |
-- |
-- |
-- |
| 1 |
100% |
8% |
-- |
-- |
1 Month |
1 |
0% |
-- |
-- |
-- |
| 1 |
0% |
-4% |
-- |
-- |
1 Week |
1 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 6 |
67% |
23% |
-28% |
293 |
1 Year |
6 |
0% |
-- |
-- |
-- |
| 8 |
63% |
11% |
-20% |
198 |
9 Month |
8 |
0% |
-- |
-- |
-- |
| 9 |
78% |
-2% |
-16% |
112 |
6 Month |
9 |
0% |
-- |
-- |
-- |
| 11 |
73% |
-3% |
-3% |
48 |
3 Month |
11 |
0% |
-- |
-- |
-- |
| 13 |
54% |
-1% |
-3% |
79 |
1 Month |
13 |
0% |
-- |
-- |
-- |
| 13 |
69% |
-1% |
-1% |
29 |
1 Week |
13 |
0% |
-- |
-- |
-- |
| Scorecards Updated 6/13/2023 07:07 PM EST |
Latest Transaction Date: |
4/10/2023 |
| Average days between Transaction and Entered Dates: |
2 |
